The significance of secukinumab in the treatment of plaque psoriasis

Marta Kasprowicz-Furmańczyk; Agnieszka Owczarczyk-Saczonek

doi:10.5114/dr.2021.113155

eISSN: 2084-9893
ISSN: 0033-2526

Dermatology Review/Przegląd Dermatologiczny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

5/2021
vol. 108

Send email

Copy url:

abstract:

Review article

The significance of secukinumab in the treatment of plaque psoriasis

Marta Kasprowicz-Furmańczyk

¹

,

Agnieszka Owczarczyk-Saczonek

¹

The Municipal Polyclinic Hospital, Olsztyn, Poland

Dermatol Rev/Przegl Dermatol 2021, 108, 372–384

DOI: https://doi.org/10.5114/dr.2021.113155

Online publish date: 2022/02/07

View full text Get citation

PlumX metrics:

Psoriasis is a chronic inflammatory skin disease that affects approximately 1–3% of the general population in Poland. It is estimated that in 70–80% of patients skin lesions are mild and require only topical medications. In severe plaque psoriasis, classic treatments often lead to a loss of efficacy, adverse effects or insufficient treatment effect, therefore it is necessary to search for new therapeutic methods. Multiple studies show that secukinumab, a fully human monoclonal antibody that selectively neutralizes interleukin-17A (IL-17A), has significant efficacy in the treatment of moderate to severe psoriasis, demonstrating a rapid onset of action and sustained response with a good safety profile. The role of secukinumab in the treatment of plaque psoriasis is discussed in this article.

keywords:

The significance of secukinumab in the treatment of plaque psoriasis

Marta Kasprowicz-Furmańczyk 1 , Agnieszka Owczarczyk-Saczonek 1

secukinumab, psoriasis, biological treatment

Marta Kasprowicz-Furmańczyk

¹

,

Agnieszka Owczarczyk-Saczonek

¹